Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, has completed a funding round worth £1.5M, including a direct investment of £650,000 from Mercia Technologies PLC.
Medical Technology
Tue, 27/09/2016 - 09:00
Wed, 21/09/2016 - 14:00
Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders
Wed, 22/06/2016 - 08:30
Results reveal key differences between digital health and other life science companies.
Thu, 05/05/2016 - 09:00
Mercia has committed follow-on capital to Medherant Ltd. Medherant’s patch, known as the TEPI-patch®, is a thin, strong, easy-to-apply and easy-to-remove patch capable of delivering higher doses of drugs.
Wed, 20/01/2016 - 13:00
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire.
Wed, 04/11/2015 - 13:00
St.
Wed, 30/09/2015 - 10:15
London, UK, 30th September 2015 / Sciad Newswire / Blue Latitude, a creative marketing consultancy specialising in healthcare, announced today that they have succ
Tue, 04/08/2015 - 12:00
Imperial Innovations is pleased to announce the launch of Orthonika, a spinout company from Imperial College London that is developing a novel knee meniscus replacement, MenisciKnit™.